This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting. We do not share any your subscription information with third parties. It is used solely to send you notifications about site content occasionally.

Rush University (Illinois, USA) researchers report that nearly 500,000 deaths in 2007 are attributable to the condition, factoring in chronic coexisting conditions that leave people weak and fragile and thereby lead to death.

Bryan James and colleagues analyzed data collected in the Religious Orders Study (began in 2004) and the Rush Memory and Aging Project (began in 1997), the total of both following 2,500 older men and women with cognitive tests and other exams. Autopsy data were available for more than 80 percent of the approximately 1,000 participants who have died so far. Deaths among participants who developed incident Alzheimer’s disease during follow-up were far more common than in those remaining dementia-free: of 516 who developed Alzheimer’s disease, 68.0 percent died, compared with 32.3 percent of those without incident Alzheimer’s. Median time to death for participants who developed Alzheimer’s disease was 2.7 years. The data from the two Rush cohorts were then extrapolated to the entire U.S. population, using vital statistics data from 2007. Careful to distinguish deaths with Alzheimer’s disease and deaths from the disease, the team estimates that 477,800 deaths in 2007 could be attributable to Alzheimer’s disease. Noting that reduction of the frequency of diagnostic assessments leads to underestimates of the attributable risk, the study authors submit that deaths from Alzheimer’s disease may be six times more common than official statistics indicate. [James B, et al. “Attributable


  1. James B, et al. “Attributable risk of mortality from incident Alzheimer’s disease” [Abstract P2–174]. Presented at Alzheimer’s Association International Conference, 20 July 2012.


blockquote.article-intro { color: #333333; font-family: "Roboto","Helvetica Neue",Helvetica,Arial,sans-serif; font-size: 15px; line-height: 1.5; }